Document ID: FDA-2016-N-0001-0003
Agency: fda
Document Type: Notice
Title: Request for Nominations on the Technical Electronic Product Radiation
Safety Standards Committee
Posted Date: 2016-01-19T05:00Z

[Federal Register Volume 81, Number 11 (Tuesday, January 19, 2016)]
[Notices]
[Page 2870]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00825]

[[Page 2870]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]

Request for Nominations on the Technical Electronic Product 
Radiation Safety Standards Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting any 
industry organizations interested in participating in the selection of 
voting industry representatives to serve on the Technical Electronic 
Product Radiation Safety Standards Committee for the Center for Devices 
and Radiological Health to notify FDA in writing. FDA is also 
requesting nominations for voting industry representatives to serve on 
the Technical Electronic Product Radiation Safety Standards Committee. 
A nominee may either be self-nominated or nominated by an organization 
to serve as a voting industry representative. Nominations will be 
accepted for current vacancies effective with this notice.

DATES: Any industry organization interested in participating in the 
selection of an appropriate voting member to represent industry 
interests must send a letter stating that interest to FDA by February 
18, 2016, (see sections I and II of this document for further details). 
Concurrently, nomination materials for prospective candidates should be 
sent to FDA by February 18, 2016.

ADDRESSES: All statements of interest from industry organizations 
interested in participating in the selection process of voting industry 
representative nomination should be sent to Margaret Ames (see FOR 
FURTHER INFORMATION CONTACT). All nominations for voting industry 
representatives may be submitted electronically by accessing the FDA 
Advisory Committee Membership Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail 
to Advisory Committee Oversight and Management Staff, Food and Drug 
Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5103, Silver 
Spring, MD 20993-0002. Information about becoming a member of an FDA 
advisory committee can also be obtained by visiting FDA's Web site at 
http://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Margaret Ames, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, rm. 5234, Silver Spring, MD 20993, 301-796-5960, FAX: 
301-847-8505, margaret.ames@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: The Agency requests nominations for voting 
industry representatives to the following advisory committee:

I. Technical Electronic Product Radiation Safety Standards Committee

    This Committee provides advice and consultation to the Commissioner 
of Food and Drugs on the technical feasibility, reasonableness, and 
practicability of performance standards for electronic products, to 
control the emission of radiation from such products, and may recommend 
electronic product radiation safety standards to the Commissioner for 
consideration.

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate voting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this document (see DATES). Within the subsequent 30 days, FDA will send 
a letter to each organization that has expressed an interest, attaching 
a complete list of all such organizations, and a list of all nominees 
along with their current resumes. The letter will also state that it is 
the responsibility of the interested organizations to confer with one 
another and to select a candidate, within 60 days after the receipt of 
the FDA letter, to serve as the voting member to represent industry 
interests for the committee. The interested organizations are not bound 
by the list of nominees in selecting a candidate. However, if no 
individual is selected within 60 days, the Commissioner will select the 
voting member to represent industry interests.

III. Application Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a voting industry representative. 
Contact information, a current curriculum vitae, and the name of the 
committee of interest should be sent to the FDA Advisory Committee 
Membership Nomination Portal (see ADDRESSES) within 30 days of 
publication of this document (see DATES). FDA will forward all 
nominations to the organizations expressing interest in participating 
in the selection process for the committee. Persons who nominate 
themselves as voting industry representatives will not participate in 
the selection process.
    FDA seeks to include the views of women, men, members of all racial 
and ethnic groups, and individuals with and without disabilities on its 
advisory committees and, therefore encourages nominations of 
appropriately qualified candidates from these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: January 11, 2016.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2016-00825 Filed 1-15-16; 8:45 am]
 BILLING CODE 4164-01-P